You are here: Industry Insights > flu vaccine

News List

Vaccitech Universal Flu Vaccine Passes Phase 2b Clinical Development Milestones americanpharmaceuticalreview
June 06, 2019
Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study – a Phase 2b, randomized, double-blind, placebo controlled, influenza challenge study being conducted in Antwerp, Belgiu
Sanofi plans to ‘airlift’ flu vaccine into UK in no-deal event pharmatimes
March 27, 2019
In the wake of Brexit and the event of a no-deal exit from the European Union, French pharmaceutical giant Sanofi has said it could potentially airlift its flu vaccine into the UK.
FluGen’s broadly protective flu vaccine clears early human test, eyes 'challenge' study fiercepharma
November 09, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains
BiondVax Moves to New Flu Vaccine Mfg. Facility fiercebiotech
August 22, 2018
BiondVax Pharmaceuticals, developer of the M-001 universal influenza vaccine candidate, has relocated to a newly constructed mid-size commercial scale manufacturing facility in Jerusalem, Israel.
FluGen Awarded $14.4 million by the DoD to Test Universal Flu Vaccine Against Mismatched Strains americanpharmaceuticacreview
October 19, 2017
Under the three-year award, FluGen will conduct two challenge-studies with RedeeFlu. In these studies, half of the participants will be vaccinated and half will receive a placebo but all will subsequently be infected with an influenza virus.
Seqirus’ adjuvanted quadrivalent flu vaccine shows better protection for young children fiercepharma
September 13, 2017
Seqirus already has the first and only FDA-approved cell-based flu vaccine, Flucelvax, for people four years and older.
BiondVax Receives Additional Grant Funding americanpharmaceuticalreview
August 21, 2017
BiondVax Pharmaceuticals announced the Israel Innovation Authority (IIA) agreed to fund up to 40% of a NIS 2.7 million (approximately US$ 750,000) budget towards ongoing development of M-001, the company's Universal Flu Vaccine candidate.
Video—Ryan Riboldi explains role of new Sanofi facility planning 70M flu shots in U.S. fiercepharma
August 08, 2017
Sanofi Pasteur has opened a new quality testing facility at its Swiftwater, Pennsylvania, campus.The company plans to ship 70 million flu shot doses to the U.S. market this year.
New research offers insights into how adjuvants increase Avian Flu Vaccine effectiveness biospectrumasia
July 14, 2017
Paper reflects systems biology analysis assessing responses to a vaccine adjuvant.
Israeli biotech BiondVax gets government help to build flu vaccine manufacturing facility fiercepharma
March 31, 2017
Israeli biotech BiondVax is looking forward to the day when its universal flu vaccine will be commercially available and has snagged some government help to prepare for manufacturing the vaccine candidate.

Previous page 1 2 3 Next page